WORKING THROUGH
VETERINARY DRUG
DEVELOPMENT IN THE
EU AND USA - Boston,
USA

Conference Date: 28 Sep 2009-22 Nov 2009
Conference Ref: V9-8109
Fee: $4850
Venue: Sheraton Boston Hotel

*This is a Residential Course - the registration fee includes four nights’ accommodation and all meals. A non-residential fee is available on request.

25% Discount for members of the Animal Health Institute, USA

Benefits in Attending the Animal Health Autumn School:

• Gain a comprehensive overview of the entire development process
• Understand the EU and US regulatory framework
• Achieve successful submission of your veterinary medicine
• Define the differences between the EU and US approach to the development of a veterinary product
• Share knowledge and experiences with other delegates and speakers from the EU and US
• Gain practical hands on experience working on case studies within the workshop sessions

INTRODUCTION AND OBJECTIVES

The development of a veterinary medicine is complex, time consuming and expensive. It requires teamwork from individuals with different scientific training and a wide range of skills. Everyone involved must be aware of the main stages in the development programme and be able to relate their responsibilities to the expertise and needs of the scientists and commercial members of the team.  Furthermore, different approaches taken by the regulatory authorities in the European Union and the USA, mean that a comprehensive development programme must be designed in order for the product to be commercialised in both the American and European regions.    

This course has been designed to demonstrate how pharmaceutical, pharmacological, toxicological and clinical investigations and regulatory management are brought together in the development programme. It will take the participants through all the stages in the development of a veterinary medicinal product for which a marketing authorisation is sought in the European Union and the USA.  Presentations will cover pharmaceutical and process development, toxicological, pharmacological, residues and ecotoxicological studies, safety risk assessments, clinical development, pharmacovigilance, regulatory and marketing input and project management.

An important part of the course will be devoted to working on case studies in the workshop sessions. The course will provide a comprehensive introduction to the entire development programme.

Please contact andrea.james@management-forum.co.uk for further information or a brochure.  To book your place on this important event, please click here.

Members of AHI, USA will receive a 25% discount off the registration fee. Please quote AHI09 when registering to receive the offered discount.  

For further information on the AHI, please click here

Meet the participants from our successful 2009 Summer School held in the UK